Filing Details
- Accession Number:
- 0001127602-12-004374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-07 16:05:34
- Reporting Period:
- 2012-02-03
- Filing Date:
- 2012-02-07
- Accepted Time:
- 2012-02-07 16:05:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410233 | Elizabeth Joan Miller | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Svp-Oncology & Neurology Srvcs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-03 | 13,333 | $55.65 | 91,072 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-03 | 13,333 | $58.50 | 77,865 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-02-03 | 13,333 | $0.00 | 13,333 | $55.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
26,667 | 2020-02-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,047 | Indirect | 401(k)/SDCP |
Footnotes
- 40,000 options granted on February 10, 2010 vest in equal annual installments beginning on the first annual anniversary of the grant date.
- The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- These underlying shares were acquired on a periodic basis by the trustees of the Company's Profit Sharing (401(k)) and Supplemental Deferred Compensation Plans. The information was obtained from the plan administrators as of a recent date. The number of shares is based on the account balance of the Company's stock fund under the Plans (which include some money market instruments), divided by the market price of the Company's stock as of that date.